The Validation and Determination of Empagliflozin Concentration in the Presence of Grapefruit Juice Using HPLC for Pharmacokinetic Applications

The Validation and Determination of Empagliflozin Concentration in the Presence of Grapefruit Juice Using HPLC for Pharmacokinetic Applications

Type 2 diabetes mellitus is a multifactorial disorder whose primary manifestation usually initiates with elevated blood sugar levels. Several antidiabetic agents are used to manage type 2 diabetes mellitus, of which empagliflozin is an oral sodium-glucose co-transporter (SGLT-2) inhibitor in the kid...

Full description

Bibliographic Details
Main Authors: Wael Abu Dayyih, Zainab Zakaraya, Mohammad Hailat, Nafe M. Al-Tawarah, Sahem Alkharabsheh, Haya Khalid Nadher, Zeyad Hailat, Samia M. Alarman, Anas Khaleel, Riad Awad
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Molecules
Subjects:
type 2 diabetes mellitus
sodium-glucose co-transporter inhibitor
(SGLT-2) inhibitor
empagliflozin
pharmacokinetics
Online Access:https://www.mdpi.com/1420-3049/29/6/1236

Internet

https://www.mdpi.com/1420-3049/29/6/1236

Similar Items